☆ 4.6 Review

A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

S100A10 Promotes Pancreatic Ductal Adenocarcinoma Cells Proliferation, Migration and Adhesion through JNK/LAMB3-LAMC2 Axis

Hai Lin et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor with a poor prognosis. S100A10, a member of the S100 protein family, has been found to be up-regulated in PDAC and associated with a worse prognosis. This study suggests that S100A10 promotes PDAC cell proliferation, migration, and adhesion through the activation of the JNK/LAMB3-LAMC2 axis, making it a potential therapeutic target for PDAC patients.

CANCERS (2023)

Add to Collection

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

The reactome pathway knowledgebase 2022

Marc Gillespie et al.

Summary: The Reactome Knowledgebase, a core resource of Elixir, provides manually curated molecular details of human biological processes, serving as a digital archive and tool for discovering functional relationships. Recent work has expanded annotations of signaling processes, drugs targeting them, infections by coronaviruses, and better analysis tools for high-throughput data and placement of unstudied proteins.

NUCLEIC ACIDS RESEARCH (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer

Bradley K. Schniers et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a dire need for better therapeutic targets. This study reveals that up-regulation of amino acid transporter SLC6A14 affects overall patient survival in PDAC. Pharmacological inhibition of SLC6A14 attenuates PDAC growth by inducing amino acid deprivation and inhibiting the mTORC1 signaling pathway.

BIOCHEMICAL JOURNAL (2022)

Add to Collection

Article Oncology

The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma

Kelly M. Herremans et al.

Summary: Interleukin-1 (IL-1) plays a crucial role in pancreatic ductal adenocarcinoma (PDAC) and is associated with immune checkpoints, immune cell types, and patient survival.

NEOPLASIA (2022)

Add to Collection

Review Oncology

Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes

Alessandro Di Federico et al.

Summary: Immunotherapy and targeted therapies have not been as successful in treating pancreatic cancer as they have in other malignancies, possibly due to the unique tumor microenvironment of pancreatic cancer. This review provides a comprehensive overview of the distinctive tumor immune microenvironment of pancreatic cancer and summarizes existing data on the use of immunotherapy and immune biomarkers in this cancer.

CANCERS (2022)

Add to Collection

Article Immunology

Controversial role of γδ T cells in pancreatic cancer

Fatemeh Nezhad Shamohammadi et al.

Summary: γδT cells are rare lymphocytes that play a cogent role in immune responses. They have anti-tumor activity, but there is controversy regarding their effects in pancreatic cancer. Depending on the local microenvironment, γδT cells can differentiate into cells that promote or suppress tumors. In immunologically cold tumors like pancreatic cancer, γδT cells are more likely to exhibit an immunosuppressive phenotype.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Add to Collection

Review Oncology

Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot

Nicholas A. Ullman et al.

Summary: This article summarizes the mechanisms of immunosuppression within the PDAC tumor microenvironment and provides an up-to-date review of completed and ongoing clinical trials using various immunotherapy strategies.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma

Cindy Neuzillet et al.

Summary: This study refined the subtypes of cancer-associated fibroblasts (CAFs) in pancreatic ductal adenocarcinoma (PDAC) using RNAseq and immunostaining, and found associations between different CAF subtypes and tumor characteristics as well as patient survival. Periostin-positive CAFs were linked to aggressive tumors, while podoplanin-positive CAFs were associated with immune-related phenotypes.

JOURNAL OF PATHOLOGY (2022)

Add to Collection

Article Health Care Sciences & Services

Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer

Qi Liu et al.

Summary: COL10A1 is significantly upregulated in pancreatic cancer tissues and high expression is correlated with worse prognosis. The TUG1/miR-144-3p/COL10A1 axis is identified as the most likely upstream noncoding RNA pathway for COL10A1 in pancreatic cancer. Additionally, expression of COL10A1 in pancreatic adenocarcinoma shows significant positive correlation with tumor immune cell infiltration, immune cell biomarkers, and immune checkpoint molecules.

JOURNAL OF HEALTHCARE ENGINEERING (2022)

Add to Collection

Article Immunology

Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer

Jiannan Xu et al.

Summary: The SLFN gene family is highly expressed in gastric cancer patients and is associated with lymph node metastasis, tumor stage, tumor grade, and poor prognosis. The genetic alterations of the SLFN family in gastric cancer are frequent, including mutations and amplifications. The SLFN family interacts with multiple genes and proteins and may be involved in immune response and immune cell infiltration in gastric cancer. Additionally, the SLFN family may regulate T cell activation and contribute to immune evasion in gastric cancer.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Editorial Material Oncology

The Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Neither Hot nor Cold Comment

Samuel J. S. Rubin et al.

Summary: This review discusses the pro- and anticancer immune responses in the tumor immune microenvironment of pancreatic ductal adenocarcinoma (PDAC) and explores their potential for the development of novel therapeutic approaches.

CANCERS (2022)

Add to Collection

Article Cell Biology

TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer

Cefan Zhou et al.

Summary: Pancreatic cancer is characterized by poor prognosis and limited therapeutic options, driving the urgent need for new therapeutic targets. This study identified TSPAN1 as an upregulated gene in pancreatic cancer, correlated with poor patient survival, and demonstrated its role in regulating autophagy. Additionally, the study revealed that TSPAN1 is regulated by MIR454-FAM83A and plays a role in the proliferation of pancreatic cancer cells.

AUTOPHAGY (2021)

Add to Collection

Article Immunology

Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma

Xueyong Zheng et al.

Summary: This study analyzed differential gene expression in PAAD and identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma, highlighting its potential as a significant predictor in the disease.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The Gene Ontology resource: enriching a GOld mine

Seth Carbon et al.

Summary: The Gene Ontology Consortium has made advancements in the last two years, such as improving the GO-CAM annotation framework, increasing the number of annotations and annotated gene products, and reviewing older annotations for consistency.

NUCLEIC ACIDS RESEARCH (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma

Yuanxiang Lu et al.

Summary: This study identified 126 PDAC-specific expressed genes enriched in cell adhesion, membrane components, signal transduction, chemical carcinogenesis, and IL-17 signaling pathway, indicating their unique role in PDAC tumorigenesis. Five genes (CEACAM5, KRT6A, KRT6B, KRT7, KRT17) with high expression levels in tumor tissues were found to be significantly correlated with PDAC patient prognosis, and KRT7 was positively correlated with KRT6A, KRT6B, KRT17 expression. Real-time PCR validated the expression levels of hub genes as consistent with RNA-seq analysis, suggesting that CEACAM5, KRT6A, KRT6B, KRT7, and KRT17 may serve as novel prognostic biomarkers and therapeutic targets for poorly differentiated PDAC.

ONCOTARGETS AND THERAPY (2021)

Add to Collection

Article Oncology

LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma

Yasuyuki Okada et al.

Summary: The overexpression of LAMC2 in PDAC is associated with poor survival outcomes and can potentially serve as a prognostic marker. Inhibition of LAMC2 in PDAC cells enhances gemcitabine sensitivity and promotes apoptosis. LAMC2 also affects cell migration and invasion abilities, and is correlated with the expression of EMT and ABC transporters.

CARCINOGENESIS (2021)

Add to Collection

Article Cell Biology

Prognostic values and immune suppression of the S100A family in pancreatic cancer

Hongkai Zhuang et al.

Summary: The study found that overexpression of S100A family members is closely related to the pathological features and prognosis of PC, and identified several CpG sites that are correlated with the expression of S100A family members and OS. Through multiple bioinformatic analyses, the study revealed the potential oncological functions of the S100A family in PC.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Add to Collection

Review Gastroenterology & Hepatology

Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer

Lorena Ostios-Garcia et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor with unique microenvironment characteristics and complex immune escape mechanisms. Immunotherapy has not been very successful in treating PDAC, except for a subset of patients with specific genetic mutations who have shown prolonged survival rates.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy

Xuefei Zhou et al.

Summary: The study demonstrates that targeting gene delivery-induced RLN can modulate macrophages to reduce tumor-associated fibrosis and promote infiltration of anti-tumor T cells. In addition, RLN gene delivery synergizes with PD-L1 blockade to enhance the effectiveness of immunotherapy against tumors.

SCIENCE ADVANCES (2021)

Add to Collection

Article Immunology

Integrative Characterization of the Role of IL27 In Melanoma Using Bioinformatics Analysis

Chunyu Dong et al.

Summary: IL27 is closely associated with the prognosis, immunotherapy response, and tumor microenvironment in melanoma patients, with its high expression inducing immune response and cell death, and being linked to improved patient outcomes.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Trypsinogen and chymotrypsinogen: potent anti-tumor agents

Aitor Gonzalez-Titos et al.

Summary: The use of trypsinogen and chymotrypsinogen in tissue repair and their potential anti-tumourigenic effects have been supported by novel evidence. Studies have shown that treatment with these enzymes can sensitize Cancer Stem Cells (CSCs) and improve the effectiveness of chemotherapy and radiotherapy in cancer patients. Further research is needed to explore the molecular targets of pancreatic enzymes for cancer treatment.

EXPERT OPINION ON BIOLOGICAL THERAPY (2021)

Add to Collection

Article Multidisciplinary Sciences

ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis

Shajedul Islam et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a common form of pancreatic cancer with poor prognosis. Gene expression analysis identified 20 differentially expressed genes (DEGs) in PDAC tissues compared to non-cancerous tissues, enriched in extracellular matrix, cell adhesion, and protein-protein interaction pathways. Hub genes such as ITGA2, LAMB3, and LAMC2 play roles in PDAC progression and may serve as therapeutic targets.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Oncology

IFI35 is involved in the regulation of the radiosensitivity of colorectal cancer cells

Yan Hu et al.

Summary: IRF1 promotes the expression of IFI35 in CRC cells, which is involved in regulating the radiation sensitivity of CRC cells and may be a target for enhancing the effectiveness of radiation therapy in CRC.

CANCER CELL INTERNATIONAL (2021)

Add to Collection

Review Medicine, General & Internal

Pancreatic Cancer: A Review

Wungki Park et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer with increasing incidence each year, resulting in a high percentage of patients being diagnosed with advanced disease. Current cytotoxic therapies for PDAC are moderately effective, emphasizing the importance of multidisciplinary management, comprehensive germline testing, and integrated supportive care for all patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Multidisciplinary Sciences

Comprehensive analysis of abnormal expression, prognostic value and oncogenic role of the hub gene FN1 in pancreatic ductal adenocarcinoma via bioinformatic analysis and in vitro experiments

Xiaohua Lei et al.

Summary: Through integrated bioinformatics analysis and in vitro experiments, we identified nine hub genes associated with PDAC, with two (FN1 and ITGA2) showing a close relationship with patient prognosis. FN1 was highlighted as having an oncogenic role in PDAC.

PEERJ (2021)

Add to Collection

Review Medicine, Research & Experimental

Turning cold tumors into hot tumors by improving T-cell infiltration

Yuan-Tong Liu et al.

Summary: Immunotherapy, particularly through immune checkpoint inhibitors, has significantly improved the treatment of malignant tumors by enhancing T cell infiltration into tumors. Understanding the mechanisms underlying cold tumors, which lack T cell infiltration, is crucial to improving immunotherapy efficacy. Strategies to transform cold tumors into hot tumors and increase T cell infiltration are discussed, along with the potential of nanomedicines in enhancing tumor immunotherapy.

THERANOSTICS (2021)

Add to Collection

Article Oncology

The COL11A1/Akt/CREB signaling axis enables mitochondrial-mediated apoptotic evasion to promote chemoresistance in pancreatic cancer cells through modulating BAX/BCL-2 function

Hui Wang et al.

Summary: COL11A1 modulates apoptotic inhibition and chemoresistance in pancreatic cancer cells by activating the Akt/CREB/BCL-2/BAX signaling pathway, suggesting it may serve as a distinct prognostic indicator and an attractive therapeutic target for PDAC.

JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma

Fabien Robin et al.

BRITISH JOURNAL OF CANCER (2020)

Add to Collection

Review Oncology

The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities

Won Jin Ho et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Add to Collection

Review Gastroenterology & Hepatology

Pancreatic cancer stroma: an update on therapeutic targeting strategies

Abdel N. Hosein et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Review Physiology

MICROENVIRONMENTAL DETERMINANTS OF PANCREATIC CANCER

Elisabeth Hessmann et al.

PHYSIOLOGICAL REVIEWS (2020)

Add to Collection

Article Oncology

Involvement of the Interferon Signaling Pathways in Pancreatic Cancer Cells

Mariko Fujisawa et al.

ANTICANCER RESEARCH (2020)

Add to Collection

Review Oncology

The old CEACAMs find their new role in tumor immunotherapy

Zi-Wen Han et al.

INVESTIGATIONAL NEW DRUGS (2020)

Add to Collection

Article Genetics & Heredity

Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8

Haruhi Fukuhisa et al.

JOURNAL OF HUMAN GENETICS (2019)

Add to Collection

Article Cell Biology

LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway

Hong Zhang et al.

CELL DEATH & DISEASE (2019)

Add to Collection

Review Oncology

Checkpoint inhibitors in pancreatic cancer

Andreas Henriksen et al.

CANCER TREATMENT REVIEWS (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF

Yunfei Liu et al.

ONCOTARGETS AND THERAPY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

ArrayExpress update - from bulk to single-cell expression data

Awais Athar et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Article Medicine, General & Internal

Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (PDAC)

Justyna Zinczuk et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)

Add to Collection

Review Oncology

Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression

Balsam Rizeq et al.

CANCER SCIENCE (2018)

Add to Collection

Article Multidisciplinary Sciences

Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers

Antonio Irigoyen et al.

PLOS ONE (2018)

Add to Collection

Article Cell Biology

PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2

Hui Shen et al.

CELL DEATH & DISEASE (2018)

Add to Collection

Review Health Care Sciences & Services

Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment

Stuart P. Atkinson et al.

JOURNAL OF PERSONALIZED MEDICINE (2018)

Add to Collection

Article Multidisciplinary Sciences

The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation

Elisabeth Jahny et al.

PLOS ONE (2017)

Add to Collection

Article Biochemistry & Molecular Biology

ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization

Guangchuang Yu et al.

MOLECULAR BIOSYSTEMS (2016)

Add to Collection

Article Multidisciplinary Sciences

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey et al.

NATURE (2016)

Add to Collection

Article Oncology

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer

Clifford J. Whatcott et al.

CLINICAL CANCER RESEARCH (2015)

Add to Collection

Article Genetics & Heredity

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Richard A. Moffitt et al.

NATURE GENETICS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Add to Collection

Article Oncology

Identification of cystatin SN as a novel biomarker for pancreatic cancer

Jie Jiang et al.

TUMOR BIOLOGY (2015)

Add to Collection

Review Oncology

Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge

Amani Makkouk et al.

CANCER RESEARCH (2015)

Add to Collection

Article Multidisciplinary Sciences

A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers

Nalin C. W. Goonesekere et al.

PLOS ONE (2014)

Add to Collection

Editorial Material Genetics & Heredity

The Cancer Genome Atlas Pan-Cancer analysis project

John N. Weinstein et al.

NATURE GENETICS (2013)

Add to Collection

Article Biotechnology & Applied Microbiology

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Guangchuang Yu et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)

Add to Collection

Editorial Material Oncology

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Ethan Cerami et al.

CANCER DISCOVERY (2012)

Add to Collection

Article Biochemistry & Molecular Biology

Effect of chymotrypsin C and related proteins on pancreatic cancer cell migration

Haibo Wang et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)

Add to Collection

Article Biochemical Research Methods

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

Mark D. Robinson et al.

BIOINFORMATICS (2010)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Conducting Meta-Analyses in R with the metafor Package

Wolfgang Viechtbauer

JOURNAL OF STATISTICAL SOFTWARE (2010)

Add to Collection

Article Biotechnology & Applied Microbiology

A scaling normalization method for differential expression analysis of RNA-seq data

Mark D. Robinson et al.

GENOME BIOLOGY (2010)

Add to Collection

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

Add to Collection

Article Biochemistry & Molecular Biology

Primary human keratinocytes externalize stratifin protein via exosomes

Claudia Chavez-Munoz et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2008)

Add to Collection

Review Oncology

Cysteine cathepsins: multifunctional enzymes in cancer

Mona Mostafa Mohamed et al.

NATURE REVIEWS CANCER (2006)

Add to Collection

Article Gastroenterology & Hepatology

PTF1α/p48 and cell proliferation

A Rodolosse et al.

GASTROENTEROLOGY (2004)

Add to Collection

Article Biochemistry & Molecular Biology

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

R Edgar et al.

NUCLEIC ACIDS RESEARCH (2002)

Add to Collection

Article Health Care Sciences & Services

Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis

JAC Sterne et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.